Skip to content
healthcare.dev

QALSODY

NDC 64406-109, tofersen, injection, from Biogen Inc..

Product NDC
64406-109
Status
Listed
Labeler
Biogen Inc.
Dosage form
INJECTION
Route
INTRATHECAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215887
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64406-109 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFERSEN100 mg/15mL

Pharmacologic classes

Antisense Oligonucleotide [EPC]; Oligonucleotides, Antisense [CS]

Package NDCNDC-11Package
64406-109-01644060109011 VIAL, SINGLE-USE in 1 CARTON (64406-109-01) / 15 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/81356b45-1cb7-4eef-88ea-e44cc18b47c5
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=64406-109

Use it

Look up 64406-109 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64406-109 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64406-109. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.